Ngenla price?

NGenla (TAF + FTC)
NGenla is Viatris’ brand name for the once‑daily fixed‑dose combination of Tenofovir Alafenamide (TAF) and Emtricitabine (FTC). It’s approved for HIV 1 treatment (and pre‑exposure prophylaxis in some jurisdictions). Because it’s a brand‑name formulation, the retail price is higher than if the two ingredients were purchased separately.

What you can expect in the U.S.

Key points

• The above are typical “list” prices. In practice, most patients pay far less thanks to insurance, pharmacy benefit manager (PBM) negotiations, manufacturer discount programs, or the Viatris Patient Assistance Program.
• If you have coverage, ask your pharmacist for the “copay” amount. In many cases, it will be a flat $25–$50 per month, or a tiered copay that scales with the drug’s cost.
• For uninsured patients, the manufacturer’s assistance program can cover the full cost (subject to eligibility). Check the Viatris website or talk to a pharmacist.

What you can expect outside the U.S.

Note: In many markets there is no generic version of the fixed‑dose TAF + FTC combo yet. Generic versions of the individual drugs (TAF and FTC) are available separately, but they don’t replace the convenience or adherence support of the single‑tablet regimen.

How to get the best price

1. Check insurance coverage

   • Ask your plan’s pharmacy benefits manager (PBM) or pharmacist to confirm the copay or coinsurance amount for NGenla.

2. Ask about discount cards or manufacturer coupons

   • Viatris offers a Viatris Patient Assistance Program that can waive the cost for eligible patients.
   • Many pharmacies also have discount cards that reduce the out‑of‑pocket price.

3. Consider a pharmacy benefit manager (PBM) discount

   • Some PBMs negotiate lower prices for brand drugs; the savings can be passed on to the patient.

4. Look into generic options

   • While there is no generic fixed‑dose combo yet, you can sometimes use separate generic TAF and FTC tablets.
   • Important: Using separate tablets can increase pill burden and may affect adherence.

5. Consult a clinical pharmacist

   • Pharmacists can sometimes identify lower‑cost pharmacies in your area or suggest alternative regimens that are more affordable and still effective.

Bottom line

• U.S. retail price: Roughly $1,200–$1,800 per month (list price).
• Insurance: Usually reduces out‑of‑pocket costs to a copay of $25–$50/month.
• Uninsured assistance: Viatris’ program can cover the cost for qualifying patients.
• Other markets: Prices vary widely; typically cheaper outside the U.S., but availability may differ.

If you’re looking for the most accurate, up‑to‑date price for your specific situation, contact your local pharmacy or the Viatris Patient Assistance Program directly. They can give you a precise quote after checking your coverage and eligibility.